Why is Penny Stock Salarius Pharmaceuticals (SLRX) Up 182% Today?
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SLRX Stock's Delisting Extension Deadlines
The Nasdaq panel gave Salarius more time to meet two major listing rules. Firstly, Salarius has until mid-August 2025 to raise its stockholders' equity to at least $2.5 million. Further, the company has until late August 2025 to get its stock price back above $1.00.
It is worth noting that Salarius received a delisting warning on April 23, 2025, as its stock had remained below $1.00 for 30 consecutive trading days. Normally, companies get 180 days to fix this, but the biotech stock did not qualify since it had already done a reverse stock split in the past year.
Road Ahead for Salarius
The compliance extension is dependent on Salarius meeting certain goals and keeping Nasdaq informed of its progress. Investors are also watching the company's planned merger with Decoy Therapeutics, a private biotech firm working on peptide conjugate therapeutics.
The merger is expected to bring new assets and funding to Salarius. Together, the companies aim to advance treatments for respiratory viruses and gastrointestinal cancers.
While Salarius stock's surge reflects renewed optimism, it is not without risk. The company remains under pressure to meet Nasdaq's deadlines and successfully close its merger. If it fails to comply, SLRX stock could be delisted.
Is SLRX a Buy or Sell?
According to the TipRanks AI analyst, SLRX stock received a score of 30 out of 100 with an Underperform rating.
Salarius' unstable financials, with falling revenue and ongoing losses, hurt its stock rating. Also, a negative P/E ratio and absence of dividends make it less appealing to value or income investors.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Consolidated Water Co Ltd (CWCO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Release Date: August 12, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Consolidated Water Co Ltd (NASDAQ:CWCO) reported a 3% increase in total revenues for Q2 2025, with a notable 23% rise in fully diluted earnings per share from continuing operations compared to the previous year. The retail and manufacturing segments showed strong performance, with revenue increases of 6% and 33% respectively, driven by higher water sales and increased production of higher margin products. The company successfully completed an expansion of its West Bay seawater desalination plant, adding an additional 1 million gallons per day of production capacity to meet growing demand in Grand Cayman. Consolidated Water Co Ltd (NASDAQ:CWCO) increased its quarterly cash dividend by 27% to $0.14 per share, reflecting strong financial health and commitment to returning value to shareholders. The company has a strong balance sheet with cash and cash equivalents totaling approximately $112.2 million as of June 30, 2025, providing ample liquidity for future investments and growth opportunities. Negative Points The Caribbean-based bulk water segment experienced a slight revenue decline due to lower fuel pass-through charges, although profitability improved due to plant efficiencies and reduced operating costs. The services segment saw a decrease in revenue, primarily due to the completion of the pilot plant testing phase of the Hawaii project, leading to reduced project expenditures until construction begins. The construction phase of the Hawaii project faces potential delays due to permits required from the client, which are outside of Consolidated Water Co Ltd (NASDAQ:CWCO)'s control. The company reported a decrease in net income and EPS from 2024 to 2025 due to discontinued operations, specifically the gain on the sale of land and project documentation for a discontinued project in Mexico. The Bahamas government has been slow in paying their bills, although there have been recent improvements in payment schedules. Q & A Highlights Warning! GuruFocus has detected 7 Warning Sign with CWCO. Q: Can you provide an overview of the market opportunities for Consolidated Water Co Ltd in the Caribbean and the U.S., particularly for PERC and REC? A: (CEO, Rick McTaggart) In the U.S., particularly in the West and Southwest, there is continued interest in wastewater projects driven by developments and small industrial projects. These projects range from $10 to $30 million in size. In California, the focus is on O&M contract renewals. In Colorado, we see opportunities for upgrades and expansions of wastewater and water treatment facilities, especially north of Denver. In the Caribbean, we are focused on the Cayman Islands and the Bahamas, with new projects like the Cat Island plants in the Bahamas. Q: How does the expansion of the Air X facility in Fort Pierce impact your manufacturing capabilities? A: (CEO, Rick McTaggart) The expansion will significantly increase our capacity by freeing up shop floor space for higher throughput on fabrication. This allows us to take on larger projects and increase revenue from the manufacturing business. The additional space will enable complex assembly work without occupying welder space, enhancing overall efficiency. Q: What is the status of the Hawaii seawater desalination project, and what permits are still required? A: (CEO, Rick McTaggart) We are waiting on two major permits: an archaeological permit, which involves ensuring no historical artifacts are affected, and a health department approval for the water supply. The archaeological studies are complete, and we are working through the regulatory process. The design is nearly finished, and we expect to submit it for health department approval soon. Q: Can you discuss the progress on the receivables from the Bahamas government? A: (CEO, Rick McTaggart) We have made progress in discussions with the Bahamas government, and they have committed to scheduled payments to bring the account current. We are optimistic about reducing the receivable in the coming months, although it is not yet reflected in the current financials. Q: With a strong cash position and expected cash generation, how do you plan to allocate capital moving forward? A: (CEO, Rick McTaggart) We are actively pursuing M&A opportunities and exploring public-private partnership projects to address water shortages in the Southwest and Texas. Our strong cash position gives us an advantage in these long-term investments. We also raised the dividend last quarter and will continue to evaluate ways to return value to shareholders. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
12 minutes ago
- Business Wire
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tandem Diabetes Care, Inc. ('Tandem' or the 'Company') (NASDAQ: TNDM) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TANDEM DIABETES CARE, INC. (TNDM), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On August 7, 2025, Tandem disclosed that a malfunction had been identified in some of its insulin pumps which could 'trigger an error resulting in a discontinuation of insulin delivery' which 'could result in hyperglycemia due to discontinuation of insulin delivery' and 'may require hospitalization or intervention from a medical professional.' The Company stated that it had sent notices to impacted customers between July 22 and 24, 2025. On this news, Tandem's stock price fell $2.87, or 19.9%, to close at $11.52 per share on August 7, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Charles Linehan, Esq., Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150 (Toll-Free: 888-773-9224) Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. Whistleblower Notice Persons with non-public information regarding Tandem should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@ About Glancy Prongay & Murray LLP Glancy Prongay & Murray LLP ('GPM') is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. GPM has been consistently ranked in the Top 50 Securities Class Action Settlements by ISS Securities Class Action Services. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM's nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPM's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Insider
20 minutes ago
- Business Insider
Morning Movers: Tapestry and Deere fall following quarterly results
Stock futures are moving lower this morning, giving back a bit of the recent strong gains that have lifted the S&P 500 and Nasdaq to record highs. Commodities are largely stable: Brent crude is slightly up, gold slightly down and Bitcoin is trading around the $120,000 level. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In pre-market trading following the latest round of inflation data, S&P 500 futures are down 0.37%, Nasdaq futures are down 0.44% and Dow futures are down 0.35%. Check out this morning's top movers from around Wall Street, compiled by The Fly, and subscribe to the Fly By on YouTube to keep ahead of what's moving before the open. HIGHER – UP AFTER EARNINGS – Vipshop (VIPS) up 3% DLocal (DLO) up 20% DOWN AFTER EARNINGS – Deere (DE) down 6% Tapestry (TPR) down 12% NetEase (NTES) down 6% Birkenstock (BIRK) down 2% Coherent (COHR) down 18% Cisco (CSCO) down 1%
